Effect of gonadectomy on the ontogeny of estrogen-binding components in rat liver cytosol. 1981

W Powell-Jones, and C Thompson, and S Raeford, and G W Lucier

These studies elucidate the ontogeny of two classes of estrogen-binding sites present in rat liver cytosol. The first class of sites is precipitated from whole cytosol fractions by ammonium sulfate (30% saturation) and exhibits characteristics of specific estrogen receptors. Detectable levels of receptors are attained during the third postnatal week. During days 30--40, receptors reach maximum concentration and remain relatively constant thereafter. The second class of sites, detected in whole cytosol fractions, possess a high binding capacity for estrogens and are present in similar amounts in male and female liver before day 34. However, between days 34--40 male levels increase dramatically while female levels remain constant. This sex difference is maintained throughout the duration of the study (160 days). Specific estrogen receptors from immature (26 days) and mature (70--80 days) rat liver have similar characteristics in terms of sedimentation properties in sucrose gradients, ligand binding specificity, and heat and pronase susceptibility. After prepuberal (19--21 days) gonadectomy, levels of receptor in subsequent adult animals of both sexes are increased approximately 40%. No alterations in receptor levels are seen after neonatal (day 1) castration of males. Prepuberal (day 19) gonadectomy does not alter the normal development of sexual differentiation of high capacity estrogen-binding sites. However, after neonatal (day 1) castration male rats, levels of those sites do not undergo sexual differentiation, and neonatally castrated adult males exhibit female levels of high capacity estrogen-binding site. These studies suggest that sexual differentiation of high capacity estrogen-binding sites may be programmed at birth by testicular androgens.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D011960 Receptors, Estrogen Cytoplasmic proteins that bind estrogens and migrate to the nucleus where they regulate DNA transcription. Evaluation of the state of estrogen receptors in breast cancer patients has become clinically important. Estrogen Receptor,Estrogen Receptors,Estrogen Nuclear Receptor,Estrogen Receptor Type I,Estrogen Receptor Type II,Estrogen Receptors Type I,Estrogen Receptors Type II,Receptor, Estrogen Nuclear,Receptors, Estrogen, Type I,Receptors, Estrogen, Type II,Nuclear Receptor, Estrogen,Receptor, Estrogen
D002352 Carrier Proteins Proteins that bind or transport specific substances in the blood, within the cell, or across cell membranes. Binding Proteins,Carrier Protein,Transport Protein,Transport Proteins,Binding Protein,Protein, Carrier,Proteins, Carrier
D002369 Castration Surgical removal or artificial destruction of gonads. Gonadectomy,Castrations,Gonadectomies
D003600 Cytosol Intracellular fluid from the cytoplasm after removal of ORGANELLES and other insoluble cytoplasmic components. Cytosols
D004958 Estradiol The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids. 17 beta-Estradiol,Estradiol-17 beta,Oestradiol,17 beta-Oestradiol,Aerodiol,Delestrogen,Estrace,Estraderm TTS,Estradiol Anhydrous,Estradiol Hemihydrate,Estradiol Hemihydrate, (17 alpha)-Isomer,Estradiol Monohydrate,Estradiol Valerate,Estradiol Valeriante,Estradiol, (+-)-Isomer,Estradiol, (-)-Isomer,Estradiol, (16 alpha,17 alpha)-Isomer,Estradiol, (16 alpha,17 beta)-Isomer,Estradiol, (17-alpha)-Isomer,Estradiol, (8 alpha,17 beta)-(+-)-Isomer,Estradiol, (8 alpha,17 beta)-Isomer,Estradiol, (9 beta,17 alpha)-Isomer,Estradiol, (9 beta,17 beta)-Isomer,Estradiol, Monosodium Salt,Estradiol, Sodium Salt,Estradiol-17 alpha,Estradiol-17beta,Ovocyclin,Progynon-Depot,Progynova,Vivelle,17 beta Estradiol,17 beta Oestradiol,Estradiol 17 alpha,Estradiol 17 beta,Estradiol 17beta,Progynon Depot
D004967 Estrogens Compounds that interact with ESTROGEN RECEPTORS in target tissues to bring about the effects similar to those of ESTRADIOL. Estrogens stimulate the female reproductive organs, and the development of secondary female SEX CHARACTERISTICS. Estrogenic chemicals include natural, synthetic, steroidal, or non-steroidal compounds. Estrogen,Estrogen Effect,Estrogen Effects,Estrogen Receptor Agonists,Estrogenic Agents,Estrogenic Compounds,Estrogenic Effect,Estrogenic Effects,Agents, Estrogenic,Agonists, Estrogen Receptor,Compounds, Estrogenic,Effects, Estrogen,Effects, Estrogenic,Receptor Agonists, Estrogen
D005260 Female Females

Related Publications

W Powell-Jones, and C Thompson, and S Raeford, and G W Lucier
August 1986, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
W Powell-Jones, and C Thompson, and S Raeford, and G W Lucier
January 1981, Journal of receptor research,
W Powell-Jones, and C Thompson, and S Raeford, and G W Lucier
July 1988, Journal of steroid biochemistry,
W Powell-Jones, and C Thompson, and S Raeford, and G W Lucier
May 1985, Anesthesia and analgesia,
W Powell-Jones, and C Thompson, and S Raeford, and G W Lucier
August 1979, Archives internationales de physiologie et de biochimie,
W Powell-Jones, and C Thompson, and S Raeford, and G W Lucier
January 1979, Problemy endokrinologii,
W Powell-Jones, and C Thompson, and S Raeford, and G W Lucier
November 1975, Life sciences,
W Powell-Jones, and C Thompson, and S Raeford, and G W Lucier
December 1971, Biochimica et biophysica acta,
W Powell-Jones, and C Thompson, and S Raeford, and G W Lucier
January 1983, Endokrynologia Polska,
W Powell-Jones, and C Thompson, and S Raeford, and G W Lucier
October 1988, Endocrinologia japonica,
Copied contents to your clipboard!